CORRECTION: Kythera Reports FDA Acceptance of ATX-101 NDA, PDUFA Date Set at May 13, 2015

By: via Benzinga
KYTHERA Biopharmaceuticals, Inc. (Nasdaq: KYTH) today announced that its New Drug Application (NDA) for ATX-101 (deoxycholic acid), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.